794
Views
26
CrossRef citations to date
0
Altmetric
Review

Influence of microenvironment on engraftment of transplanted β-cells

Pages 1-7 | Received 02 Dec 2010, Accepted 06 Dec 2010, Published online: 02 Feb 2011

References

  • Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia. 1973;9:486–91.
  • CITR Research Group. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant. 2009;18:753–67.
  • Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–8.
  • Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–30.
  • Eich T, Eriksson O, Sundin A, Estrada S, Brandhorst D, Brandhorst H, Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation. 2007;84:893–8.
  • Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 1999;48:1907–14.
  • Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039–45.
  • Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes. 2001;50:489–95.
  • Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 1995;72:889–95.
  • Bottino R, Fernandez LA, Ricordi C, Lehmann R, Tsan MF, Oliver R, Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes. 1998;47:316–23.
  • Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–9.
  • Moberg L. The role of the innate immunity in islet transplantation. Ups J Med Sci. 2005;110:17–55.
  • Eriksson O, Eich T, Sundin A, Tibell A, Tufveson G, Andersson H, Positron emission tomography in clinical islet transplantation. Am J Transplant. 2009;9:2816–24.
  • Olsson R. The microvasculature of endogenous and transplanted pancreatic islets [dissertation]. Uppsala: Uppsala University; 2006.
  • Desai NM, Goss JA, Deng S, Wolf BA, Markmann E, Palanjian M, Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation. 2003;76:1623–5.
  • Shapiro AM, Gallant HL, Hao EG, Lakey JR, McCready T, Rajotte RV, The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit. 2005;27:35–7.
  • Hayek A, Beattie GM. Intrapancreatic islet transplantation in experimental diabetes in the rat. Metabolism. 1992;41:1367–9.
  • Stagner JI, Mokshagundam SP, Samols E. Induction of mild hypoglycemia by islet transplantation to the pancreas. Transplant Proc. 1998;30:635–6.
  • Lau J, Kampf C, Mattsson G, Nyqvist D, Köhler M, Berggren PO, Beneficial role of pancreatic microenvironment for angiogenesis in transplanted pancreatic islets. Cell Transplantation. 2009;18:23–30.
  • Carlsson PO, Liss P, Andersson A, Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes. 1998;47:1027–32.
  • Rafael E, Tibell A, Ryden M, Lundgren T, Savendahl L, Borgstrom B, Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant. 2008;8:458–62.
  • Svensson J, Lau J, Sandberg M, Carlsson PO. High vascular density and oxygenation of pancreatic islets transplanted in clusters into striated muscle. Cell Transplant. 2010 Nov 5 (Epub ahead of print).
  • Christoffersson G, Henriksnas J, Johansson L, Rolny C, Ahlstrom H, Caballero-Corbalan J, Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes. 2010;59:2569–78.
  • Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes. 2002;51:1362–6.
  • Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab. 2002;87:5418–23.
  • Lau J, Carlsson PO. Low revascularization of human islets when experimentally transplanted into the liver. Transplantation. 2009;87:322–5.
  • Johansson A, Lau J, Sandberg M, Borg LA, Magnusson PU, Carlsson PO. Endothelial cell signalling supports pancreatic beta cell function in the rat. Diabetologia. 2009;52:2385–94.
  • Olerud J. Role of thrombospondin-1 in endogenous and transplanted pancreatic islets [dissertation]. Uppsala: Uppsala University; 2009.
  • Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO. Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology. 2006;147:2315–24.
  • Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell. 2006;10:397–405.
  • Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia. 1995;38:543–9.
  • Westermark GT, Westermark P, Nordin A, Tornelius E, Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci. 2003;108:193–203.
  • Westermark GT, Westermark P, Berne C, Korsgren O. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 2008;359:977–9.
  • Lee Y, Ravazzola M, Park BH, Bashmakov YK, Orci L, Unger RH. Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin. Diabetes. 2007;56:2295–301.
  • Markmann JF, Rosen M, Siegelman ES, Soulen MC, Deng S, Barker CF, Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes. 2003;52:1591–4.
  • Bhargava R, Senior PA, Ackerman TE, Ryan EA, Paty BW, Lakey JR, Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes. 2004;53:1311–17.
  • Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes. 1997;46:28–33.
  • Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002;51:3428–34.
  • Zhou H, Zhang T, Bogdani M, Oseid E, Parazzoli S, Vantyghem MC, Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes. 2008;57:1567–74.
  • Mattsson G, Jansson L, Nordin A, Andersson A, Carlsson PO. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes. 2004;53:948–54.
  • Lau J, Mattsson G, Carlsson C, Nyqvist D, Kohler M, Berggren PO, Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes. 2007;56:1544–50.
  • Lund T, Korsgren O, Aursnes IA, Scholz H, Foss A. Sustained reversal of diabetes following islet transplantation to striated musculature in the rat. J Surg Res. 2010;160:145–54.
  • Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 2002;51:1779–84.
  • Goto M, Johansson H, Maeda A, Elgue G, Korsgren O, Nilsson B. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation. 2004;77:741–7.
  • Moberg L, Olsson A, Berne C, Felldin M, Foss A, Kallen R, Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation. 2003;76:1285–8.
  • Cabric S, Sanchez J, Lundgren T, Foss A, Felldin M, Kallen R, Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes. 2007;56:2008–15.
  • Johansson U, Elgue G, Nilsson B, Korsgren O. Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant. 2005;5:2632–9.
  • Emamaullee JA, Stanton L, Schur C, Shapiro AM. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes. 2007;56:1289–98.
  • Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai SX, The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008;57:1556–66.
  • Johansson M, Olerud J, Jansson L, Carlsson PO. Prolactin treatment improves engraftment and function of transplanted pancreatic islets. Endocrinology. 2009;150:1646–53.
  • Yamamoto T, Mita A, Ricordi C, Messinger S, Miki A, Sakuma Y, Prolactin supplementation to culture medium improves beta-cell survival. Transplantation. 2010;89:1328–35.
  • Lund T, Fosby B, Korsgren O, Scholz H, Foss A. Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int. 2008;21:669–78.
  • Toso C, McCall M, Emamaullee J, Merani S, Davis J, Edgar R, Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int. 2010;23:259–65.
  • Toyoda K, Okitsu T, Yamane S, Uonaga T, Liu X, Harada N, GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis. Biochem Biophys Res Commun. 2008;367:793–8.
  • Juang JH, Kuo CH, Wu CH, Juang C. Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets. Cell Transplant. 2008;17:641–7.
  • Gangemi A, Salehi P, Hatipoglu B, Martellotto J, Barbaro B, Kuechle JB, Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant. 2008;8:1250–61.
  • Faradji RN, Tharavanij T, Messinger S, Froud T, Pileggi A, Monroy K, Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation. 2008;86:1658–65.
  • Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes. 2004;53:963–70.
  • Shimoda M, Chen S, Noguchi H, Matsumoto S, Grayburn PA. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia. 2010;53:1669–79.
  • Olerud J, Johansson M, Lawler J, Welsh N, Carlsson PO. Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets. Diabetes. 2008;57:1870–7.
  • Duprez IR, Johansson U, Nilsson B, Korsgren O, Magnusson PU. Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation. Ups J Med Sci. 2011;116:8–17.
  • Ito T, Itakura S, Todorov I, Rawson J, Asari S, Shintaku J, Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation. 2010;89:1438–45.
  • Johansson U, Rasmusson I, Niclou SP, Forslund N, Gustavsson L, Nilsson B, Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes. 2008;57:2393–401.
  • Kang S, Park HS, Jung HS, Park KS. Effective revascularisation and enhancement of islet engraftment by cotransplantation of islets with endothelial progenitor cells. Diabetologia. 2010;53(Suppl 1):S60.
  • Olerud J, Kanaykina N, Vasylovska S, King D, Sandberg M, Jansson L, Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets. Diabetologia. 2009;52:2594–601.
  • Blomeier H, Zhang X, Rives C, Brissova M, Hughes E, Baker M, Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation. 2006;82:452–9.